Literature DB >> 14563784

Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.

Michael T Griffin1, Minoru Matsui, Darakhshanda Shehnaz, Khurram Z Ansari, Makoto M Taketo, Toshiya Manabe, Frederick J Ehlert.   

Abstract

We investigated the subtypes of the muscarinic receptor mediating short-term heterologous desensitization in the isolated ileum. Treatment of the ileum from C57BL/6 mice with acetylcholine (30 microM) for 20 min caused a subsequent decrease in contractile sensitivity to both prostaglandin F2alpha (PGF2alpha) and the muscarinic agonist, oxotremorine-M. This subsensitivity was characterized by 7- and 3-fold increases in the EC50 values of the agonists, respectively, with no significant effect on the maximal response. The subsensitivity to PGF2alpha was prevented in both M2 and M3 muscarinic receptor knockout mice. Similarly, the subsensitivity to oxotremorine-M was prevented in M2 knockout mice. Acetylcholine-mediated desensitization of histamine-induced contractions in the guinea pig ileum was inhibited by both M2- and M3-selective muscarinic antagonists with high potency, although careful analysis of the data suggested behavior more consistent with an M2 antagonistic profile. Modeling studies showed that the competitive antagonism of response contingent upon activation of two receptor subtypes should exhibit a pharmacological profile similar to that of the least sensitive signaling pathway. Our results demonstrate that muscarinic agonist-mediated short-term heterologous desensitization of intestinal smooth muscle is contingent upon activation of both M2 and M3 muscarinic receptors and that activation of either receptor by itself is insufficient to cause desensitization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563784     DOI: 10.1124/jpet.103.055327

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Regulation of bladder muscarinic receptor subtypes by experimental pathologies.

Authors:  M R Ruggieri; A S Braverman
Journal:  Auton Autacoid Pharmacol       Date:  2006-07

Review 2.  Cholinergic modulation of the hippocampal region and memory function.

Authors:  Juhee Haam; Jerrel L Yakel
Journal:  J Neurochem       Date:  2017-08       Impact factor: 5.372

3.  Multiple muscarinic pathways mediate the suppression of voltage-gated Ca2+ channels in mouse intestinal smooth muscle cells.

Authors:  Yasuyuki Tanahashi; Toshihiro Unno; Hayato Matsuyama; Toshiaki Ishii; Masahisa Yamada; Jürgen Wess; Seiichi Komori
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

4.  The guinea pig ileum lacks the direct, high-potency, M(2)-muscarinic, contractile mechanism characteristic of the mouse ileum.

Authors:  Michael T Griffin; Minoru Matsui; Rennolds S Ostrom; Frederick J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-07       Impact factor: 3.000

5.  Regulation of the perilymphatic-endolymphatic water shunt in the cochlea by membrane translocation of aquaporin-5.

Authors:  A Eckhard; A Dos Santos; W Liu; M Bassiouni; H Arnold; C Gleiser; B Hirt; C Harteneck; M Müller; H Rask-Andersen; H Löwenheim
Journal:  Pflugers Arch       Date:  2015-07-25       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.